Tenaya Therapeutics, Inc. Common Stock

TNYA US87990A1060

💰
Capitalization
Small-cap

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.

🔗
Website
https://www.tenayatherapeutics.com
Annual Performance 1
2021 2022 2023 2024 2025
23% -90% 61% -56% 0%
Annual Insiders Turnover, USD 2

1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);

Insider Activity
📊
Transactions
31
🙍
Insiders
7
Person Price Shares Total Published Completed
Ali Faraz
CEO 		1.25
USD 		3,893
Sold 		4,878
USD 		18/08/2025 18/08/2025
Higa Tomohiro
SR VP 		1.25
USD 		523
Sold 		655
USD 		18/08/2025 18/08/2025
Ali Faraz
CEO 		1.25
USD 		4,920
Sold 		6,165
USD 		18/08/2025 18/08/2025
Tingley Whittemore
CMO 		1.25
USD 		1,608
Sold 		2,015
USD 		18/08/2025 18/08/2025
Higa Tomohiro
SR VP 		1.25
USD 		1,722
Sold 		2,158
USD 		18/08/2025 18/08/2025
Higa Tomohiro
SR VP 		1.25
USD 		717
Sold 		898
USD 		18/08/2025 18/08/2025
Ali Faraz
CEO 		1.25
USD 		5,720
Sold 		7,167
USD 		18/08/2025 18/08/2025
Tingley Whittemore
CMO 		1.25
USD 		1,837
Sold 		2,302
USD 		18/08/2025 18/08/2025
Tingley Whittemore
CMO 		1.25
USD 		1,608
Sold 		2,015
USD 		18/08/2025 18/08/2025
Tingley Whittemore
CMO 		0.44
USD 		2,937
Sold 		1,300
USD 		16/05/2025 16/05/2025

Integrated EOD Stock Data and Insider Transactions Chart

Sign in or subscribe to include Tenaya Therapeutics, Inc. Common Stock to your watchlist and receive automatic alerts for upcoming transactions.

The visibility of insider buy and sell transactions on this chart should not be the sole factor in your decision to buy or sell a particular stock. Always consider the following dynamic reports for a broader understanding of stock market activities:

 

Historical Performance
1M 3M 6M 1Y 3Y 5Y All Time
-30% -64% -71% -77% 0% 0% -91%
Last 52W Low 52W High All-Time Low All-Time High β
1.77 0.39 3.78 0.39 29.58
Company Insiders
Person / Entity Transactions Turnover, USD Average, USD First Last
Goeddel David V 2 34,999,997.80 17,499,998.90 12/02/2024 05/03/2025
Ali Faraz 9 90,339.64 10,037.74 16/02/2024 18/08/2025
Hoey Timothy 4 85,577.67 21,394.42 16/02/2024 05/03/2024
Tingley Whittemore 7 67,221.95 9,603.14 16/02/2024 18/08/2025
Patterson Leone D 1 30,477.86 30,477.86 16/02/2024 16/02/2024
Saito Chihiro 4 11,626.66 2,906.66 16/08/2024 18/11/2024
Higa Tomohiro 4 4,326.74 1,081.68 16/05/2025 18/08/2025

Insiders marked in yellow represent long-term insiders. These are individuals who have engaged in transactions for over 3 years and have conducted at least 10 transactions or reached a cumulative turnover of $1M USD. When examining transaction clusters, we prioritize those conducted by long-term insiders for analysis.

Connected Companies 3
Name ISIN Ticker
NGM BIOPHARMACEUTICALS, INC. US62921N1054 NGM

3 the firms where the current insiders have executed transactions.

Stock Advanced Metrics
Delta Correlation subscribe 🔒
Upper Bound of Standardized Transaction Amount (ubsta), USD 4 subscribe 🔒

4 represents the maximum expected transaction amount for a company's insiders, calculated based on historical data. It provides insight into the typical range of insider transaction amounts and helps in identifying unusually large transactions.

5 a proprietary metric reflecting the consistency of insider trading behavior within a company. A higher discipline index suggests more regular and predictable insider transactions.